These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7673254)

  • 1. Different effects on mitogenesis and transformation of a mutation at tyrosine 1251 of the insulin-like growth factor I receptor.
    Miura M; Surmacz E; Burgaud JL; Baserga R
    J Biol Chem; 1995 Sep; 270(38):22639-44. PubMed ID: 7673254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-like growth factor I receptor signaling in transformation by src oncogenes.
    Valentinis B; Morrione A; Taylor SJ; Baserga R
    Mol Cell Biol; 1997 Jul; 17(7):3744-54. PubMed ID: 9199308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyrosine residues in the C-terminal domain of the insulin-like growth factor-I receptor mediate mitogenic and tumorigenic signals.
    Esposito DL; Blakesley VA; Koval AP; Scrimgeour AG; LeRoith D
    Endocrinology; 1997 Jul; 138(7):2979-88. PubMed ID: 9202243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The critical role of Shc in insulin-like growth factor-I-mediated mitogenesis and differentiation in 3T3-L1 preadipocytes.
    Boney CM; Gruppuso PA; Faris RA; Frackelton AR
    Mol Endocrinol; 2000 Jun; 14(6):805-13. PubMed ID: 10847583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired Shc, Ras, and MAPK activation but normal Akt activation in FL5.12 cells expressing an insulin-like growth factor I receptor mutated at tyrosines 1250 and 1251.
    Leahy M; Lyons A; Krause D; O'Connor R
    J Biol Chem; 2004 Apr; 279(18):18306-13. PubMed ID: 14963047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a mutation at tyrosine 950 of the insulin-like growth factor I receptor on the growth and transformation of cells.
    Miura M; Li S; Baserga R
    Cancer Res; 1995 Feb; 55(3):663-7. PubMed ID: 7834637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumorigenic and mitogenic capacities are reduced in transfected fibroblasts expressing mutant insulin-like growth factor (IGF)-I receptors. The role of tyrosine residues 1250, 1251, and 1316 in the carboxy-terminus of the IGF-I receptor.
    Blakesley VA; Kalebic T; Helman LJ; Stannard B; Faria TN; Roberts CT; LeRoith D
    Endocrinology; 1996 Feb; 137(2):410-7. PubMed ID: 8593783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of insulin receptor substrate-1 and Shc on insulin-like growth factor I receptor signaling in early passages of cultured human fibroblasts.
    Takahashi Y; Tobe K; Kadowaki H; Katsumata D; Fukushima Y; Yazaki Y; Akanuma Y; Kadowaki T
    Endocrinology; 1997 Feb; 138(2):741-50. PubMed ID: 9003010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of interleukin-2-dependent signal transduction through the Shc/Grb2 adapter pathway. Interleukin-2-dependent mitogenesis does not require Shc phosphorylation or receptor association.
    Evans GA; Goldsmith MA; Johnston JA; Xu W; Weiler SR; Erwin R; Howard OM; Abraham RT; O'Shea JJ; Greene WC
    J Biol Chem; 1995 Dec; 270(48):28858-63. PubMed ID: 7499411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitogenicity and transforming activity of the insulin-like growth factor-I receptor with mutations in the tyrosine kinase domain.
    Li S; Ferber A; Miura M; Baserga R
    J Biol Chem; 1994 Dec; 269(51):32558-64. PubMed ID: 7798258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional importance of Shc tyrosine 317 on insulin signaling in Rat1 fibroblasts expressing insulin receptors.
    Ishihara H; Sasaoka T; Ishiki M; Takata Y; Imamura T; Usui I; Langlois WJ; Sawa T; Kobayashi M
    J Biol Chem; 1997 Apr; 272(14):9581-6. PubMed ID: 9083103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of dimerization on signal transduction and biological function of oncogenic Ros, insulin, and insulin-like growth factor I receptors.
    Chan JL; Lai M; Wang LH
    J Biol Chem; 1997 Jan; 272(1):146-53. PubMed ID: 8995240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ret oncogene signal transduction via a IRS-2/PI 3-kinase/PKB and a SHC/Grb-2 dependent pathway: possible implication for transforming activity in NIH3T3 cells.
    Hennige AM; Lammers R; Arlt D; Höppner W; Strack V; Niederfellner G; Seif FJ; Häring HU; Kellerer M
    Mol Cell Endocrinol; 2000 Sep; 167(1-2):69-76. PubMed ID: 11000521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stabilization of the Ras oncoprotein by the insulin-like growth factor 1 receptor during anchorage-independent growth.
    Gatzka M; Prisco M; Baserga R
    Cancer Res; 2000 Aug; 60(15):4222-30. PubMed ID: 10945634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tyrosine phosphorylation-dependent and -independent role of Shc in the regulation of IGF-1-induced mitogenesis and glycogen synthesis.
    Sasaoka T; Ishiki M; Wada T; Hori H; Hirai H; Haruta T; Ishihara H; Kobayashi M
    Endocrinology; 2001 Dec; 142(12):5226-35. PubMed ID: 11713219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased insulin sensitivity in IGF-I receptor--deficient brown adipocytes.
    Mur C; Valverde AM; Kahn CR; Benito M
    Diabetes; 2002 Mar; 51(3):743-54. PubMed ID: 11872675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the Shc phosphotyrosine interaction/phosphotyrosine binding domain and tyrosine phosphorylation sites in polyoma middle T antigen-mediated cell transformation.
    Blaikie PA; Fournier E; Dilworth SM; Birnbaum D; Borg JP; Margolis B
    J Biol Chem; 1997 Aug; 272(33):20671-7. PubMed ID: 9252386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional importance of amino-terminal domain of Shc for interaction with insulin and epidermal growth factor receptors in phosphorylation-independent manner.
    Sasaoka T; Ishihara H; Sawa T; Ishiki M; Morioka H; Imamura T; Usui I; Takata Y; Kobayashi M
    J Biol Chem; 1996 Aug; 271(33):20082-7. PubMed ID: 8702728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoplastic transformation induced by insulin receptor substrate-1 overexpression requires an interaction with both Grb2 and Syp signaling molecules.
    Tanaka S; Ito T; Wands JR
    J Biol Chem; 1996 Jun; 271(24):14610-6. PubMed ID: 8662827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational analysis of the mitogenic and transforming activities of the insulin-like growth factor I receptor.
    Hongo A; D'Ambrosio C; Miura M; Morrione A; Baserga R
    Oncogene; 1996 Mar; 12(6):1231-8. PubMed ID: 8649825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.